|
|
Volumn 37, Issue 2, 2002, Pages 147-161
|
|
COX-1/COX-2 inhibitors based on the methanone moiety
|
|
Author keywords
COX 1 COX 2 inhibition; N (Aroylphenyl)amides and sulphonamides; Structure activity relationships
|
|
Indexed keywords
2 BENZOYL 1 (4 CHLOROPHENYLSULFONAMIDO)BENZENE;
2 BENZOYL 1 (4 METHOXYPHENYLSULFONAMIDO)BENZENE;
2 BENZOYL 1 (4 METHYLPHENYLSULFONAMIDO)BENZENE;
2 BENZOYL 1 [4 (TERT BUTYL)PHENYLSULFONAMIDO]BENZENE;
2 BENZOYL 1 PHENYLSULFONAMIDOBENZENE;
AMFENAC;
AMIDE;
BENZAMIDE DERIVATIVE;
CYCLOOXYGENASE 1;
CYCLOOXYGENASE 1 INHIBITOR;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
DICLOFENAC;
INDOMETACIN;
KETOPROFEN;
N (2 BENZOYLPHENYL)METHANESULFONAMIDE;
N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE;
N [2 (2 PHENYLBENZOYL)PHENYL]METHANESULFONAMIDE;
N [2 (2 THIENYLCARBONYL)PHENYL]METHANESULFONAMIDE;
N [2 (4 METHYLBENZOYL)PHENYL]METHANESULFONAMIDE;
N [2 (4 METHYLSULFANYLBENZOYL)PHENYL]METHANESULFONAMIDE;
N [2 [(4 TERT BUTYL)BENZOYL]PHENYL]METHANESULFONAMIDE;
N1 (BENZOYLPHENYL) 3,5 DI(TRIFLUOROMETHYL) 1 BENZENESULFONAMIDE;
N1 [2 (4 METHYLBENZOYL)PHENYL] 4 METHYL 1 BENZENESULFONAMIDE;
N1 [2 [4 (TERT BUTYL)BENZOYL]PHENYL] 4 METHYL 1 BENZENESULFONAMIDE;
N2 (2 BENZOYLPHENYL) 2 NAPHTHALENESULFONAMIDE;
N2 (2 BENZOYLPHENYL) 2 THIOPHENESULFONAMIDE;
SULFONAMIDE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ANIMAL CELL;
ARTICLE;
CHEMICAL MODIFICATION;
CONTROLLED STUDY;
DRUG POTENCY;
DRUG SCREENING;
DRUG SYNTHESIS;
ENZYME ACTIVITY;
ENZYME INHIBITION;
ENZYME SPECIFICITY;
HUMAN;
HUMAN CELL;
MONOCYTE;
NONHUMAN;
NORMAL HUMAN;
STRUCTURE ACTIVITY RELATION;
SWINE;
THROMBOCYTE;
ANIMALS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
BLOOD PLATELETS;
CYCLOOXYGENASE 1;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
DRUG EVALUATION, PRECLINICAL;
ISOENZYMES;
MOLECULAR STRUCTURE;
OXAZINES;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
|
EID: 0036175354
PISSN: 02235234
EISSN: None
Source Type: Journal
DOI: 10.1016/S0223-5234(01)01330-7 Document Type: Article |
|
Times cited : (30)
|
|
References (37)
|
